OPENAI ACQUIRES ORCHESTRA BIO TO ACCELERATE DRUG DEVELOPMENT

Summary from the TLDR AI newsletter

OpenAI acquired Orchestra Bio to combine its AI-powered drug development coordination platform with Rosalind, its suite of life sciences AI tools.